SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
DOR BioPharma, Inc. Awarded Two Grants Totaling $5.3 Million To Advance Ricin Toxin And Botulinum Toxin Vaccine Programs